Your browser doesn't support javascript.
loading
Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial.
Suo, Xiaohui; Fang, Zheng; Wang, Dongmei; Zhao, Liyun; Liu, Jie; Li, Hong; Ma, Xiaojun; Zhang, Congcong; Zhao, Xuemei; Shi, Rui; Wu, Yan; Jiao, Zongjiu; Song, Jiaojie; Zhang, Ling; Li, Ling; Zhang, Suping; Lu, Xinxiao; Yuan, Linyu; Gao, Sifeng; Zhang, Jilei; Liu, Kaiqi; Zhao, Xingli; Bai, Guanchen; Mi, Yingchang.
Affiliation
  • Suo X; Department of Hematology, Handan Central Hospital, Handan, Hebei, China.
  • Fang Z; Department of Hematology, The Second People's Hospital of Guiyang, Guiyang, Guizhou, China.
  • Wang D; Department of Hematology, Harrison International Peace Hospital, Hengshui, Hebei, China.
  • Zhao L; Department of Hematology, People Hospital of XingTai, Xing Tai, Hebei, China.
  • Liu J; Department of Hematology, Sinopharm Tongmei General Hospital, Datong, Shanxi, China.
  • Li H; Department of Hematology, Daqing Oilfied General Hospital, Daqing, Heilongjiang, China.
  • Ma X; Department of Hematology, Handan Central Hospital, Handan, Hebei, China.
  • Zhang C; Department of Hematology, Handan Central Hospital, Handan, Hebei, China.
  • Zhao X; Department of Hematology, The Second People's Hospital of Guiyang, Guiyang, Guizhou, China.
  • Shi R; Department of Hematology, Harrison International Peace Hospital, Hengshui, Hebei, China.
  • Wu Y; Department of Hematology, Harrison International Peace Hospital, Hengshui, Hebei, China.
  • Jiao Z; Department of Hematology, People Hospital of XingTai, Xing Tai, Hebei, China.
  • Song J; Department of Hematology, People Hospital of XingTai, Xing Tai, Hebei, China.
  • Zhang L; Department of Hematology, Sinopharm Tongmei General Hospital, Datong, Shanxi, China.
  • Li L; Department of Hematology, Inner Mongolia People's Hospital, Huhehaote, Neimenggu, China.
  • Zhang S; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Lu X; Department of Hematology, Oncology Center, Tianjin People's Hospital, Tianjin, China.
  • Yuan L; Department of Hematology, Oncology Center, Tianjin People's Hospital, Tianjin, China.
  • Gao S; Department of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China.
  • Zhang J; Department of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China.
  • Liu K; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
  • Zhao X; Department of Hematology, Oncology Center, Tianjin People's Hospital, Tianjin, China.
  • Bai G; Department of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China.
  • Mi Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem. Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Hematol Oncol ; 42(4): e3296, 2024 Jul.
Article in En | MEDLINE | ID: mdl-39041653
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Daunorubicin / Bridged Bicyclo Compounds, Heterocyclic / Cytarabine Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Hematol Oncol Year: 2024 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Daunorubicin / Bridged Bicyclo Compounds, Heterocyclic / Cytarabine Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Hematol Oncol Year: 2024 Document type: Article Affiliation country: